GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Antibiotice SA (BSE:ATB) » Definitions » Cyclically Adjusted Revenue per Share

Antibiotice (BSE:ATB) Cyclically Adjusted Revenue per Share : lei0.67 (As of Dec. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Antibiotice Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Antibiotice's adjusted revenue per share for the three months ended in Dec. 2023 was lei0.205. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is lei0.67 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Antibiotice's average Cyclically Adjusted Revenue Growth Rate was 8.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Antibiotice was 7.50% per year. The lowest was 7.50% per year. And the median was 7.50% per year.

As of today (2024-05-16), Antibiotice's current stock price is lei1.92. Antibiotice's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was lei0.67. Antibiotice's Cyclically Adjusted PS Ratio of today is 2.87.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Antibiotice was 2.95. The lowest was 0.81. And the median was 0.97.


Antibiotice Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Antibiotice's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Antibiotice Cyclically Adjusted Revenue per Share Chart

Antibiotice Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.54 0.57 0.62 0.67

Antibiotice Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.62 0.65 0.66 0.67 0.67

Competitive Comparison of Antibiotice's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Antibiotice's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Antibiotice's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Antibiotice's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Antibiotice's Cyclically Adjusted PS Ratio falls into.



Antibiotice Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Antibiotice's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.205/129.4194*129.4194
=0.205

Current CPI (Dec. 2023) = 129.4194.

Antibiotice Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.090 99.695 0.117
201406 0.133 100.560 0.171
201409 0.100 100.428 0.129
201412 0.152 99.070 0.199
201503 0.078 99.621 0.101
201506 0.119 100.684 0.153
201509 0.125 100.392 0.161
201512 0.170 99.792 0.220
201603 0.082 100.470 0.106
201606 0.132 101.688 0.168
201609 0.124 101.861 0.158
201612 0.157 101.863 0.199
201703 0.083 102.862 0.104
201706 0.137 103.349 0.172
201709 0.130 104.136 0.162
201712 0.153 104.011 0.190
201803 0.088 105.290 0.108
201806 0.147 106.317 0.179
201809 0.124 106.507 0.151
201812 0.184 105.998 0.225
201903 0.097 107.251 0.117
201906 0.160 108.070 0.192
201909 0.104 108.329 0.124
201912 0.219 108.420 0.261
202003 0.110 108.902 0.131
202006 0.108 108.767 0.129
202009 0.085 109.815 0.100
202012 0.204 109.897 0.240
202103 0.098 111.754 0.113
202106 0.142 114.631 0.160
202109 0.126 115.734 0.141
202112 0.179 117.630 0.197
202203 0.191 121.301 0.204
202206 0.179 125.017 0.185
202209 0.170 125.227 0.176
202212 0.180 125.222 0.186
202303 0.266 127.348 0.270
202306 0.204 128.729 0.205
202309 0.219 129.860 0.218
202312 0.205 129.419 0.205

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Antibiotice  (BSE:ATB) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Antibiotice's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1.92/0.67
=2.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Antibiotice was 2.95. The lowest was 0.81. And the median was 0.97.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Antibiotice Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Antibiotice's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Antibiotice (BSE:ATB) Business Description

Industry
Traded in Other Exchanges
N/A
Address
1 Valea Lupului Street, Iasi, ROU, 707410
Antibiotice Ord is a Romania based company engaged in manufacturing generic medicines. It primarily develops and produces generic medicines for human use, veterinary medicines and active substance Nystatin. The group's generic medicines are primarily targeted at patients with infections, dermatological, cardiovascular, digestive tract diseases or diseases of the musculoskeletal system. It manufactures firm powders for solutions for injection and suspensions for injection (penicillins), capsules, tablets, suppositories and topical preparations (ointments, gels, creams).

Antibiotice (BSE:ATB) Headlines

No Headlines